Mutation frequency of SMAD4 is estimated about 50% in pancreatic cancer, about 30% in colon cancer whereas the frequencies in prostate, breast, liver and lung cancer are lower9.33, 34. This evidence concerns the gene SMAD4 and familial pancreatic carcinoma.